T-DM1 targets HER2 on the cell surface; after HER2-mediated internalization, the DM1 payload binds beta-tubulin to disrupt microtubules, causing mitotic arrest and apoptosis in HER2-positive cells. Beta-tubulin expression itself is not the basis for targeting.